TreeWAS – Variant ID: rs12188917

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
J45.9 Asthma, unspecified	1.000	0.000	0.000
J45 Asthma	0.896	0.104	0.000
J45.0 Predominantly allergic asthma	0.874	0.126	0.000
J45.8 Mixed asthma	0.642	0.358	0.000
J45.1 Nonallergic asthma	0.642	0.358	0.000
J40-J47 Chronic lower respiratory diseases	0.036	0.964	0.000
J44 Other chronic obstructive pulmonary disease	0.029	0.971	0.000
J44.8 Other specified chronic obstructive pulmonary disease	0.027	0.973	0.000
J41 Simple and mucopurulent chronic bronchitis	0.026	0.974	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.026	0.974	0.000
J43 Emphysema	0.025	0.975	0.000
J42 Unspecified chronic bronchitis	0.025	0.975	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.025	0.975	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.024	0.976	0.000
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified	0.024	0.976	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.023	0.977	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.022	0.978	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.022	0.978	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.022	0.978	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.021	0.979	0.000
T39.1 4-Aminophenol derivatives	0.021	0.979	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.021	0.979	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.021	0.979	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.021	0.979	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.020	0.980	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.020	0.980	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.020	0.980	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.020	0.980	0.000
J43.8 Other emphysema	0.020	0.980	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.020	0.980	0.000
T39.0 Salicylates	0.020	0.980	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.019	0.981	0.000
J41.8 Mixed simple and mucopurulent chronic bronchitis	0.019	0.981	0.000
J41.1 Mucopurulent chronic bronchitis	0.019	0.981	0.000
J41.0 Simple chronic bronchitis	0.019	0.981	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.019	0.981	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.019	0.981	0.000
T40.2 Other opioids	0.019	0.981	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.018	0.981	0.000
T43.6 Psychostimulants with abuse potential	0.018	0.982	0.000
J43.1 Panlobular emphysema	0.018	0.982	0.000
J43.0 MacLeod's syndrome	0.018	0.982	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.018	0.982	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.018	0.982	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.018	0.982	0.000
T36 Poisoning by systemic antibiotics	0.018	0.982	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.018	0.982	0.000
T40.6 Other and unspecified narcotics	0.018	0.982	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.018	0.982	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.018	0.982	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.018	0.982	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.018	0.982	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.018	0.982	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.018	0.982	0.000
T44.0 Anticholinesterase agents	0.018	0.982	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.018	0.982	0.000
T43.9 Psychotropic drug, unspecified	0.017	0.982	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.017	0.982	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.017	0.982	0.000
J43.2 Centrilobular emphysema	0.017	0.983	0.000
J43.9 Emphysema, unspecified	0.017	0.983	0.000
T50.4 Drugs affecting uric acid metabolism	0.017	0.983	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.017	0.983	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.017	0.983	0.000
T39.4 Antirheumatics, not elsewhere classified	0.017	0.983	0.000
T39.2 Pyrazolone derivatives	0.017	0.983	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.017	0.983	0.000
T43.2 Other and unspecified antidepressants	0.017	0.983	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.016	0.983	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.017	0.983	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.016	0.984	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.016	0.984	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.016	0.984	0.000
T46.7 Peripheral vasodilators	0.016	0.984	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.016	0.984	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.016	0.984	0.000
T50.8 Diagnostic agents	0.016	0.984	0.000
T50.7 Analeptics and opioid receptor antagonists	0.016	0.984	0.000
T50.5 Appetite depressants	0.016	0.984	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.016	0.984	0.000
T50.1 Loop [high-ceiling] diuretics	0.016	0.984	0.000
T50.0 Mineralocorticoids and their antagonists	0.016	0.984	0.000
J46 Status asthmaticus	0.015	0.984	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.015	0.984	0.000
T40.8 Lysergide [LSD]	0.015	0.984	0.000
T40.7 Cannabis (derivatives)	0.015	0.984	0.000
T40.5 Cocaine	0.015	0.984	0.000
T40.3 Methadone	0.015	0.984	0.000
T40.1 Heroin	0.015	0.984	0.000
T40.0 Opium	0.015	0.984	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.015	0.985	0.000
T47.0 Histamine H(2)-receptor antagonists	0.015	0.985	0.000
T38.9 Other and unspecified hormone antagonists	0.015	0.985	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.015	0.985	0.000
T38.7 Androgens and anabolic congeners	0.015	0.985	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.015	0.985	0.000
T38.5 Other oestrogens and progestogens	0.015	0.985	0.000
T38.4 Oral contraceptives	0.015	0.985	0.000
T38.2 Antithyroid drugs	0.015	0.985	0.000
T38.0 Glucocorticoids and synthetic analogues	0.015	0.985	0.000
T49.9 Topical agent, unspecified	0.015	0.985	0.000
T49.8 Other topical agents	0.015	0.985	0.000
T49.7 Dental drugs, topically applied	0.015	0.985	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.015	0.985	0.000
T49.5 Ophthalmological drugs and preparations	0.015	0.985	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.015	0.985	0.000
T49.3 Emollients, demulcents and protectants	0.015	0.985	0.000
T49.2 Local astringents and local detergents	0.015	0.985	0.000
T49.1 Antipruritics	0.015	0.985	0.000
T42.0 Hydantoin derivatives	0.015	0.985	0.000
T46.1 Calcium-channel blockers	0.015	0.985	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.014	0.986	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.014	0.986	0.000
T48.5 Anti-common-cold drugs	0.014	0.986	0.000
T48.4 Expectorants	0.014	0.986	0.000
T48.3 Antitussives	0.014	0.986	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.014	0.986	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.014	0.986	0.000
T48.0 Oxytocic drugs	0.014	0.986	0.000
T38.1 Thyroid hormones and substitutes	0.014	0.986	0.000
T45.5 Anticoagulants	0.014	0.986	0.000
T45.2 Vitamins, not elsewhere classified	0.014	0.986	0.000
T42.3 Barbiturates	0.014	0.986	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.014	0.986	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.014	0.986	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.014	0.986	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.014	0.986	0.000
T37.5 Antiviral drugs	0.014	0.986	0.000
T37.4 Anthelminthics	0.014	0.986	0.000
T37.3 Other antiprotozoal drugs	0.014	0.986	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.014	0.986	0.000
T37.1 Antimycobacterial drugs	0.014	0.986	0.000
T37.0 Sulphonamides	0.014	0.986	0.000
T41.5 Therapeutic gases	0.014	0.986	0.000
T41.4 Anaesthetic, unspecified	0.014	0.986	0.000
T41.3 Local anaesthetics	0.014	0.986	0.000
T41.2 Other and unspecified general anaesthetics	0.014	0.986	0.000
T41.1 Intravenous anaesthetics	0.014	0.986	0.000
T41.0 Inhaled anaesthetics	0.014	0.986	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.013	0.986	0.000
T45.8 Other primarily systemic and haematological agents	0.013	0.986	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.013	0.986	0.000
T45.6 Fibrinolysis-affecting drugs	0.013	0.986	0.000
T45.4 Iron and its compounds	0.013	0.986	0.000
T45.3 Enzymes, not elsewhere classified	0.013	0.986	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.013	0.987	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.013	0.987	0.000
T47.7 Emetics	0.013	0.987	0.000
T47.6 Antidiarrhoeal drugs	0.013	0.987	0.000
T47.5 Digestants	0.013	0.987	0.000
T47.4 Other laxatives	0.013	0.987	0.000
T47.3 Saline and osmotic laxatives	0.013	0.987	0.000
T47.2 Stimulant laxatives	0.013	0.987	0.000
T36.9 Systemic antibiotic, unspecified	0.013	0.987	0.000
T36.8 Other systemic antibiotics	0.013	0.987	0.000
T36.7 Antifungal antibiotics, systemically used	0.013	0.987	0.000
T36.6 Rifamycins	0.013	0.987	0.000
T36.5 Aminoglycosides	0.013	0.987	0.000
T36.4 Tetracyclines	0.013	0.987	0.000
T36.3 Macrolides	0.013	0.987	0.000
T36.2 Chloramphenicol group	0.013	0.987	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.013	0.987	0.000
T42.1 Iminostilbenes	0.013	0.987	0.000
J44.9 Chronic obstructive pulmonary disease, unspecified	0.013	0.987	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.013	0.987	0.000
T42.2 Succinimides and oxazolidinediones	0.013	0.987	0.000
T45.0 Antiallergic and antiemetic drugs	0.013	0.987	0.000
T36.0 Penicillins	0.013	0.987	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.012	0.988	0.000
J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection	0.011	0.989	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.010	0.990	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.010	0.990	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.010	0.990	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.010	0.990	0.000
T40.4 Other synthetic narcotics	0.010	0.990	0.000
G58.8 Other specified mononeuropathies	0.007	0.993	0.000
C18.9 Colon, unspecified	0.000	0.994	0.006
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.000	0.994	0.006
M16.0 Primary coxarthrosis, bilateral	0.006	0.994	0.000
B44.9 Aspergillosis, unspecified	0.005	0.995	0.000
M23.26 Derangement of meniscus due to old tear or injury (Other and unspecified lateral meniscus)	0.000	0.995	0.005
E23.0 Hypopituitarism	0.000	0.995	0.005
J40 Bronchitis, not specified as acute or chronic	0.004	0.996	0.000
B44 Aspergillosis	0.004	0.996	0.000
C18.3 Hepatic flexure	0.000	0.996	0.004
C18 Malignant neoplasm of colon	0.000	0.996	0.004
B44.1 Other pulmonary aspergillosis	0.004	0.996	0.000
M77.47 Metatarsalgia-Ankle/Foot	0.004	0.996	0.000
N32.0 Bladder-neck obstruction	0.000	0.996	0.004
E23.2 Diabetes insipidus	0.000	0.996	0.004
B95.5 Unspecified streptococcus as the cause of diseases classified to other chapters	0.004	0.996	0.000
H54.7 Unspecified visual loss	0.004	0.996	0.000
C18.2 Ascending colon	0.000	0.997	0.003
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.000	0.997	0.003
D22.1 Melanocytic naevi of eyelid, including canthus	0.003	0.997	0.000
B44.8 Other forms of aspergillosis	0.003	0.997	0.000
B44.7 Disseminated aspergillosis	0.003	0.997	0.000
B44.2 Tonsillar aspergillosis	0.003	0.997	0.000
B44.0 Invasive pulmonary aspergillosis	0.003	0.997	0.000
E23 Hypofunction and other disorders of pituitary gland	0.000	0.997	0.003
B37.3 Candidiasis of vulva and vagina	0.003	0.997	0.000
C18.8 Overlapping lesion of colon	0.000	0.997	0.003
E04.9 Non-toxic goitre, unspecified	0.000	0.997	0.003
B37.8 Candidiasis of other sites	0.003	0.997	0.000
C85.1 B-cell lymphoma, unspecified	0.000	0.997	0.003
C18.5 Splenic flexure	0.000	0.997	0.003
H54.0 Blindness, both eyes	0.003	0.997	0.000
C18.6 Descending colon	0.000	0.997	0.003
N39.4 Other specified urinary incontinence	0.000	0.997	0.003
J98.9 Respiratory disorder, unspecified	0.003	0.997	0.000
B37 Candidiasis	0.003	0.997	0.000
B35-B49 Mycoses	0.003	0.997	0.000
C18.1 Appendix	0.000	0.997	0.003
J99.8 Respiratory disorders in other diseases classified elsewhere	0.003	0.997	0.000
C54.1 Endometrium	0.003	0.997	0.000
C18.7 Sigmoid colon	0.000	0.997	0.003
H83.0 Labyrinthitis	0.003	0.997	0.000
T80.8 Other complications following infusion, transfusion and therapeutic injection	0.003	0.997	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.000	0.997	0.003
C85.0 Lymphosarcoma	0.000	0.997	0.003
T80.2 Infections following infusion, transfusion and therapeutic injection	0.003	0.997	0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified	0.000	0.997	0.003
E23.1 Drug-induced hypopituitarism	0.000	0.997	0.003
J98.0 Diseases of bronchus, not elsewhere classified	0.003	0.997	0.000
H54 Blindness and low vision	0.003	0.997	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.000	0.997	0.003
E23.7 Disorder of pituitary gland, unspecified	0.000	0.997	0.003
H57.9 Disorder of eye and adnexa, unspecified	0.000	0.997	0.003
J98 Other respiratory disorders	0.003	0.997	0.000
Z52.4 Kidney donor	0.003	0.997	0.000
C18.4 Transverse colon	0.000	0.997	0.003
J99 Respiratory disorders in diseases classified elsewhere	0.003	0.997	0.000
Z96.8 Presence of other specified functional implants	0.003	0.997	0.000
N76.0 Acute vaginitis	0.000	0.997	0.003
T42.4 Benzodiazepines	0.002	0.997	0.000
G58 Other mononeuropathies	0.003	0.997	0.000
B49 Unspecified mycosis	0.002	0.997	0.000
B37.1 Pulmonary candidiasis	0.002	0.998	0.000
J98.4 Other disorders of lung	0.002	0.998	0.000
H54.6 Unqualified visual loss, one eye	0.002	0.998	0.000
Z54.0 Convalescence following surgery	0.000	0.998	0.002
B37.7 Candidal septicaemia	0.002	0.998	0.000
B37.6 Candidal endocarditis	0.002	0.998	0.000
B37.5 Candidal meningitis	0.002	0.998	0.000
E23.6 Other disorders of pituitary gland	0.000	0.998	0.002
B48 Other mycoses, not elsewhere classified	0.002	0.998	0.000
B47 Mycetoma	0.002	0.998	0.000
B46 Zygomycosis	0.002	0.998	0.000
B45 Cryptococcosis	0.002	0.998	0.000
B43 Chromomycosis and phaeomycotic abscess	0.002	0.998	0.000
B42 Sporotrichosis	0.002	0.998	0.000
B41 Paracoccidioidomycosis	0.002	0.998	0.000
B40 Blastomycosis	0.002	0.998	0.000
B39 Histoplasmosis	0.002	0.998	0.000
B38 Coccidioidomycosis	0.002	0.998	0.000
B36 Other superficial mycoses	0.002	0.998	0.000
J95-J99 Other diseases of the respiratory system	0.002	0.998	0.000
K83.8 Other specified diseases of biliary tract	0.002	0.998	0.000
B37.2 Candidiasis of skin and nail	0.002	0.998	0.000
I31.9 Disease of pericardium, unspecified	0.002	0.998	0.000
I82.8 Embolism and thrombosis of other specified veins	0.002	0.998	0.000
C67.6 Ureteric orifice	0.000	0.998	0.002
B37.4 Candidiasis of other urogenital sites	0.002	0.998	0.000
Z33 Pregnant state, incidental	0.000	0.998	0.002
J86.0 Pyothorax with fistula	0.002	0.998	0.000
H54.3 Unqualified visual loss, both eyes	0.002	0.998	0.000
H54.2 Low vision, both eyes	0.002	0.998	0.000
H54.1 Blindness, one eye, low vision, other eye	0.002	0.998	0.000
L43.9 Lichen planus, unspecified	0.000	0.998	0.002
J86.9 Pyothorax without fistula	0.002	0.998	0.000
J98.3 Compensatory emphysema	0.002	0.998	0.000
Z89.6 Acquired absence of leg above knee	0.000	0.998	0.002
J99.1 Respiratory disorders in other diffuse connective tissue disorders	0.002	0.998	0.000
J86 Pyothorax	0.002	0.998	0.000
J98.6 Disorders of diaphragm	0.002	0.998	0.000
J98.5 Diseases of mediastinum, not elsewhere classified	0.002	0.998	0.000
T80 Complications following infusion, transfusion and therapeutic injection	0.002	0.998	0.000
B35 Dermatophytosis	0.002	0.998	0.000
C67.0 Trigone of bladder	0.000	0.998	0.002
S42.30 Fracture of shaft of humerus (closed)	0.000	0.998	0.002
C67.8 Overlapping lesion of bladder	0.000	0.998	0.002
G58.0 Intercostal neuropathy	0.002	0.998	0.000
H54.4 Blindness, one eye	0.002	0.998	0.000
H54.5 Low vision, one eye	0.002	0.998	0.000
J98.2 Interstitial emphysema	0.002	0.998	0.000
J99.0 Rheumatoid lung disease	0.002	0.998	0.000
H11.8 Other specified disorders of conjunctiva	0.000	0.998	0.002
L30.9 Dermatitis, unspecified	0.002	0.998	0.000
H11.0 Pterygium	0.000	0.998	0.002
Z36.9 Antenatal screening, unspecified	0.000	0.998	0.002
B36.8 Other specified superficial mycoses	0.002	0.998	0.000
B36.3 Black piedra	0.002	0.998	0.000
B36.2 White piedra	0.002	0.998	0.000
B36.1 Tinea nigra	0.002	0.998	0.000
B36.0 Pityriasis versicolor	0.002	0.998	0.000
B38.9 Coccidioidomycosis, unspecified	0.002	0.998	0.000
B38.8 Other forms of coccidioidomycosis	0.002	0.998	0.000
B38.7 Disseminated coccidioidomycosis	0.002	0.998	0.000
B38.4 Coccidioidomycosis meningitis	0.002	0.998	0.000
B38.3 Cutaneous coccidioidomycosis	0.002	0.998	0.000
B38.2 Pulmonary coccidioidomycosis, unspecified	0.002	0.998	0.000
B38.1 Chronic pulmonary coccidioidomycosis	0.002	0.998	0.000
B38.0 Acute pulmonary coccidioidomycosis	0.002	0.998	0.000
B39.9 Histoplasmosis, unspecified	0.002	0.998	0.000
B39.5 Histoplasmosis duboisii	0.002	0.998	0.000
B39.4 Histoplasmosis capsulati, unspecified	0.002	0.998	0.000
B39.3 Disseminated histoplasmosis capsulati	0.002	0.998	0.000
B39.2 Pulmonary histoplasmosis capsulati, unspecified	0.002	0.998	0.000
B39.1 Chronic pulmonary histoplasmosis capsulati	0.002	0.998	0.000
B39.0 Acute pulmonary histoplasmosis capsulati	0.002	0.998	0.000
B40.9 Blastomycosis, unspecified	0.002	0.998	0.000
B40.8 Other forms of blastomycosis	0.002	0.998	0.000
B40.7 Disseminated blastomycosis	0.002	0.998	0.000
B40.3 Cutaneous blastomycosis	0.002	0.998	0.000
B40.2 Pulmonary blastomycosis, unspecified	0.002	0.998	0.000
B40.1 Chronic pulmonary blastomycosis	0.002	0.998	0.000
B40.0 Acute pulmonary blastomycosis	0.002	0.998	0.000
B41.9 Paracoccidioidomycosis, unspecified	0.002	0.998	0.000
B41.8 Other forms of paracoccidioidomycosis	0.002	0.998	0.000
B41.7 Disseminated paracoccidioidomycosis	0.002	0.998	0.000
B41.0 Pulmonary paracoccidioidomycosis	0.002	0.998	0.000
B42.9 Sporotrichosis, unspecified	0.002	0.998	0.000
B42.8 Other forms of sporotrichosis	0.002	0.998	0.000
B42.7 Disseminated sporotrichosis	0.002	0.998	0.000
B42.1 Lymphocutaneous sporotrichosis	0.002	0.998	0.000
B42.0 Pulmonary sporotrichosis	0.002	0.998	0.000
B43.9 Chromomycosis, unspecified	0.002	0.998	0.000
B43.8 Other forms of chromomycosis	0.002	0.998	0.000
B43.2 Subcutaneous phaeomycotic abscess and cyst	0.002	0.998	0.000
B43.1 Phaeomycotic brain abscess	0.002	0.998	0.000
B43.0 Cutaneous chromomycosis	0.002	0.998	0.000
B45.9 Cryptococcosis, unspecified	0.002	0.998	0.000
B45.8 Other forms of cryptococcosis	0.002	0.998	0.000
B45.7 Disseminated cryptococcosis	0.002	0.998	0.000
B45.3 Osseous cryptococcosis	0.002	0.998	0.000
B45.2 Cutaneous cryptococcosis	0.002	0.998	0.000
B45.1 Cerebral cryptococcosis	0.002	0.998	0.000
B45.0 Pulmonary cryptococcosis	0.002	0.998	0.000
B46.9 Zygomycosis, unspecified	0.002	0.998	0.000
B46.8 Other zygomycoses	0.002	0.998	0.000
B46.5 Mucormycosis, unspecified	0.002	0.998	0.000
B46.4 Disseminated mucormycosis	0.002	0.998	0.000
B46.3 Cutaneous mucormycosis	0.002	0.998	0.000
B46.2 Gastro-intestinal mucormycosis	0.002	0.998	0.000
B46.1 Rhinocerebral mucormycosis	0.002	0.998	0.000
B46.0 Pulmonary mucormycosis	0.002	0.998	0.000
B47.9 Mycetoma, unspecified	0.002	0.998	0.000
B47.1 Actinomycetoma	0.002	0.998	0.000
B47.0 Eumycetoma	0.002	0.998	0.000
B48.8 Other specified mycoses	0.002	0.998	0.000
B48.7 Opportunistic mycoses	0.002	0.998	0.000
B48.4 Penicillosis	0.002	0.998	0.000
B48.3 Geotrichosis	0.002	0.998	0.000
B48.2 Allescheriasis	0.002	0.998	0.000
B48.1 Rhinosporidiosis	0.002	0.998	0.000
B48.0 Lobomycosis	0.002	0.998	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.000	0.998	0.002
G58.9 Mononeuropathy, unspecified	0.002	0.998	0.000
O43.8 Other placental disorders	0.002	0.998	0.000
F33.9 Recurrent depressive disorder, unspecified	0.002	0.998	0.000
J96 Respiratory failure, not elsewhere classified	0.002	0.998	0.000
M88.90 Paget's disease of bone, unspecified (Multiple sites)	0.002	0.998	0.000
B36.9 Superficial mycosis, unspecified	0.002	0.998	0.000
C54 Malignant neoplasm of corpus uteri	0.002	0.998	0.000
J47 Bronchiectasis	0.002	0.998	0.000
G58.7 Mononeuritis multiplex	0.002	0.998	0.000
Z31.0 Tuboplasty or vasoplasty after previous sterilisation	0.000	0.998	0.002
H11.3 Conjunctival haemorrhage	0.000	0.998	0.002
M16.7 Other secondary coxarthrosis	0.002	0.998	0.000
M77.4 Metatarsalgia	0.002	0.998	0.000
B37.9 Candidiasis, unspecified	0.002	0.998	0.000
K13.0 Diseases of lips	0.000	0.998	0.002
C67 Malignant neoplasm of bladder	0.000	0.998	0.002
H11 Other disorders of conjunctiva	0.000	0.998	0.002
T80.9 Unspecified complication following infusion, transfusion and therapeutic injection	0.002	0.998	0.000
T80.6 Other serum reactions	0.002	0.998	0.000
T80.5 Anaphylactic shock due to serum	0.002	0.998	0.000
T80.4 Rh incompatibility reaction	0.002	0.998	0.000
T80.3 ABO incompatibility reaction	0.002	0.998	0.000
T80.0 Air embolism following infusion, transfusion and therapeutic injection	0.002	0.998	0.000
B35.9 Dermatophytosis, unspecified	0.002	0.998	0.000
B35.8 Other dermatophytoses	0.002	0.998	0.000
B35.5 Tinea imbricata	0.002	0.998	0.000
B35.4 Tinea corporis	0.002	0.998	0.000
B35.2 Tinea manuum	0.002	0.998	0.000
B35.0 Tinea barbae and tinea capitis	0.002	0.998	0.000
M10.99 Gout, unspecified (Site unspecified)	0.002	0.998	0.000
J85-J86 Suppurative and necrotic conditions of lower respiratory tract	0.002	0.998	0.000
C67.3 Anterior wall of bladder	0.000	0.998	0.002
I31.3 Pericardial effusion (noninflammatory)	0.002	0.998	0.000
K59.8 Other specified functional intestinal disorders	0.000	0.998	0.002
B35.1 Tinea unguium	0.002	0.998	0.000
J98.8 Other specified respiratory disorders	0.002	0.998	0.000
L30.8 Other specified dermatitis	0.002	0.998	0.000
B95.4 Other streptococcus as the cause of diseases classified to other chapters	0.002	0.998	0.000
L94.0 Localised scleroderma [morphea]	0.002	0.998	0.000
J95 Postprocedural respiratory disorders, not elsewhere classified	0.002	0.998	0.000
B35.6 Tinea cruris	0.002	0.998	0.000
D73.4 Cyst of spleen	0.002	0.998	0.000
M88.9 Paget's disease of bone, unspecified	0.002	0.998	0.000
T80.1 Vascular complications following infusion, transfusion and therapeutic injection	0.002	0.998	0.000
B95.3 Streptococcus pneumoniae as the cause of diseases classified to other chapters	0.002	0.998	0.000
H11.1 Conjunctival degenerations and deposits	0.000	0.998	0.002
J96.9 Respiratory failure, unspecified	0.001	0.998	0.000
J96.1 Chronic respiratory failure	0.001	0.998	0.000
J96.0 Acute respiratory failure	0.001	0.998	0.000
M88.99 Paget's disease of bone, unspecified (Site unspecified)	0.002	0.998	0.000
I31.0 Chronic adhesive pericarditis	0.002	0.998	0.000
L73.9 Follicular disorder, unspecified	0.002	0.998	0.000
C54.8 Overlapping lesion of corpus uteri	0.002	0.998	0.000
C54.3 Fundus uteri	0.002	0.998	0.000
C54.2 Myometrium	0.002	0.998	0.000
C54.0 Isthmus uteri	0.002	0.998	0.000
C54.9 Corpus uteri, unspecified	0.002	0.998	0.000
I31 Other diseases of pericardium	0.002	0.998	0.000
M77.49 Metatarsalgia-Site unspec	0.001	0.998	0.000
M77.48 Metatarsalgia-Other	0.001	0.998	0.000
M77.46 Metatarsalgia-Lower Leg	0.001	0.998	0.000
M77.45 Metatarsalgia-Pelvic/Thigh	0.001	0.998	0.000
M77.44 Metatarsalgia-Hand	0.001	0.998	0.000
M77.43 Metatarsalgia-Forearm	0.001	0.998	0.000
M77.42 Metatarsalgia-Upper arm	0.001	0.998	0.000
M77.41 Metatarsalgia-Shldr region	0.001	0.998	0.000
M77.40 Metatarsalgia-Mult sites	0.001	0.998	0.000
K12.1 Other forms of stomatitis	0.000	0.998	0.002
N31.8 Other neuromuscular dysfunction of bladder	0.000	0.998	0.002
C18.0 Caecum	0.000	0.998	0.002
C67.5 Bladder neck	0.000	0.998	0.002
M82.11 Osteoporosis in endocrine disorders (Shoulder region)	0.000	0.998	0.002
B35.3 Tinea pedis	0.002	0.998	0.000
C67.7 Urachus	0.000	0.998	0.001
H11.2 Conjunctival scars	0.000	0.998	0.001
H54.9 Unspecified visual impairment (binocular)	0.002	0.998	0.000
C67.1 Dome of bladder	0.000	0.998	0.002
H11.9 Disorder of conjunctiva, unspecified	0.000	0.998	0.002
J95.9 Postprocedural respiratory disorder, unspecified	0.001	0.998	0.000
T63.4 Venom of other arthropods	0.000	0.998	0.002
C67.2 Lateral wall of bladder	0.000	0.998	0.002
K38.1 Appendicular concretions	0.002	0.998	0.000
R76.8 Other specified abnormal immunological findings in serum	0.002	0.998	0.000
Chapter X Diseases of the respiratory system	0.002	0.998	0.000
M88.95 Paget's disease of bone, unspecified (Pelvic region and thigh)	0.001	0.998	0.000
M41.95 Scoliosis, unspecified (Thoracolumbar region)	0.000	0.998	0.001
D73.5 Infarction of spleen	0.001	0.998	0.000
D73.1 Hypersplenism	0.001	0.998	0.000
D73 Diseases of spleen	0.002	0.998	0.000
E46 Unspecified protein-energy malnutrition	0.000	0.998	0.002
D73.3 Abscess of spleen	0.001	0.998	0.000
H72.8 Other perforations of tympanic membrane	0.000	0.998	0.002
J95.5 Postprocedural subglottic stenosis	0.001	0.998	0.000
J95.4 Mendelson's syndrome	0.001	0.998	0.000
J95.3 Chronic pulmonary insufficiency following surgery	0.001	0.998	0.000
J95.2 Acute pulmonary insufficiency following nonthoracic surgery	0.001	0.998	0.000
J95.1 Acute pulmonary insufficiency following thoracic surgery	0.001	0.998	0.000
G31.8 Other specified degenerative diseases of nervous system	0.000	0.998	0.001
H83 Other diseases of inner ear	0.001	0.998	0.000
J96.09 Acute respiratory failure; Type unspecified	0.001	0.998	0.000
J96.01 Acute respiratory failure; Type II [hypercapnic]	0.001	0.998	0.000
J96.00 Acute respiratory failure; Type I [hypoxic]	0.001	0.998	0.000
J96.19 Chronic respiratory failure; Type unspecified	0.001	0.998	0.000
J96.11 Chronic respiratory failure; Type II [hypercapnic]	0.001	0.998	0.000
J96.10 Chronic respiratory failure; Type I [hypoxic]	0.001	0.998	0.000
J96.99 Respiratory failure, unspecified; Type unspecified	0.001	0.998	0.000
J96.91 Respiratory failure unspecified; Type II [hypercapnic]	0.001	0.998	0.000
J96.90 Respiratory failure, unspecified; Type I [hypoxic]	0.001	0.998	0.000
M88.98 Paget's disease of bone, unspecified (Other)	0.001	0.998	0.000
M88.97 Paget's disease of bone, unspecified (Ankle and foot)	0.001	0.998	0.000
M88.96 Paget's disease of bone, unspecified (Lower leg)	0.001	0.998	0.000
M88.94 Paget's disease of bone, unspecified (Hand)	0.001	0.998	0.000
M88.93 Paget's disease of bone, unspecified (Forearm)	0.001	0.998	0.000
M88.92 Paget's disease of bone, unspecified (Upper arm)	0.001	0.998	0.000
M88.91 Paget's disease of bone, unspecified (Shoulder region)	0.001	0.998	0.000
D73.8 Other diseases of spleen	0.001	0.998	0.000
S12.20 Fracture of other specified cervical vertebra (closed)	0.000	0.999	0.001
G60.0 Hereditary motor and sensory neuropathy	0.000	0.999	0.001
N76.8 Other specified inflammation of vagina and vulva	0.000	0.999	0.001
L30 Other dermatitis	0.001	0.999	0.000
C53.9 Cervix uteri, unspecified	0.001	0.999	0.000
I27.2 Other secondary pulmonary hypertension	0.001	0.999	0.000
I31.8 Other specified diseases of pericardium	0.001	0.999	0.000
I31.2 Haemopericardium, not elsewhere classified	0.001	0.999	0.000
L72.9 Follicular cyst of skin and subcutaneous tissue, unspecified	0.001	0.999	0.000
Q54.9 Hypospadias, unspecified	0.001	0.999	0.000
N76.2 Acute vulvitis	0.000	0.999	0.001
Z89.4 Acquired absence of foot and ankle	0.000	0.999	0.001
J85 Abscess of lung and mediastinum	0.001	0.999	0.000
A41.0 Septicaemia due to Staphylococcus aureus	0.000	0.999	0.001
C55 Malignant neoplasm of uterus, part unspecified	0.001	0.999	0.000
M43.16 Spondylolisthesis (Lumbar region)	0.001	0.999	0.000
B95.2 Streptococcus, group D, as the cause of diseases classified to other chapters	0.001	0.999	0.000
D73.0 Hyposplenism	0.001	0.999	0.000
F33.1 Recurrent depressive disorder, current episode moderate	0.001	0.999	0.000
H83.3 Noise effects on inner ear	0.001	0.999	0.000
I82.2 Embolism and thrombosis of vena cava	0.001	0.999	0.000
L94.8 Other specified localised connective tissue disorders	0.001	0.999	0.000
M16.2 Coxarthrosis resulting from dysplasia, bilateral	0.001	0.999	0.000
B95 Streptococcus and staphylococcus as the cause of diseases classified to other chapters	0.001	0.999	0.000
D73.9 Disease of spleen, unspecified	0.001	0.999	0.000
D73.2 Chronic congestive splenomegaly	0.001	0.999	0.000
I28.8 Other specified diseases of pulmonary vessels	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations